Cargando…
Assessment of the usefulness of prognostic Van Nuys Prognostic Index in the treatment in ductal carcinoma in situ in 15-year observation
Ductal carcinoma in situ, a marginal fraction of the mammary gland diseases, is recognized in 25% of breast cancers detected with mammographic screening. The aim of the study was to assess the prognostic value of Van Nuys Prognostic Index, serving to determine the method of treatment according to th...
Autores principales: | Kunkiel, Michał, Niwińska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608918/ https://www.ncbi.nlm.nih.gov/pubmed/34811426 http://dx.doi.org/10.1038/s41598-021-02126-0 |
Ejemplares similares
-
The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ
por: Gilleard, Onur, et al.
Publicado: (2008) -
Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast—15-Year Follow-Up
por: Niwińska, Anna, et al.
Publicado: (2022) -
A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay
por: Lei, Rachel Y., et al.
Publicado: (2020) -
The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021) -
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
por: Toss, Michael S., et al.
Publicado: (2020)